February 1, 2013 / 2:05 PM / in 5 years

CORRECTED-BRIEF-Merck says continues to believe in osteoporosis drug

(Corrects spelling of drug)

Feb 1 (Reuters) - Feb 1 (Reuters) - Merck & Co Inc : * CEO says continues to believe in potential of osteoporosis drug odanacatib * Said it made decision to delay seeking U.S. approval of drug on its own, without FDA prodding * Says it will delay marketing application in order to include additional data from an extension trial (Reporting By Ransdell Pierson)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below